Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Praxis Precision Medicines, Inc. (PRAX) had Free Cash Flow per Share of $-7.86 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-73.93M |
|
-- |
|
-- |
|
$78.36M |
|
$-78.36M |
|
$4.42M |
|
$-73.93M |
|
$-73.93M |
|
$-73.93M |
|
$-73.93M |
|
$-73.93M |
|
$-73.93M |
|
$-78.36M |
|
$-79.05M |
|
21.98M |
|
21.98M |
|
$-3.36 |
|
$-3.36 |
|
| Balance Sheet Financials | |
$273.84M |
|
$0.17M |
|
$122.54M |
|
$396.39M |
|
$52.88M |
|
-- |
|
-- |
|
$52.88M |
|
$343.50M |
|
$343.50M |
|
$343.50M |
|
21.17M |
|
| Cash Flow Statement Financials | |
$-172.74M |
|
$17.24M |
|
$89.66M |
|
$215.79M |
|
$149.94M |
|
$-65.84M |
|
$24.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-172.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.52% |
|
-21.52% |
|
-18.65% |
|
-21.52% |
|
$16.23 |
|
|
Free Cash Flow per Share |
$-7.86 |
$-7.86 |
|